New Study Reveals Lung Cancer Pill Reduces Risk of Death by Half, Media Reports

In a groundbreaking global study spanning a decade, researchers have discovered that a daily pill called osimertinib can reduce the risk of dying from lung cancer by 51%. The results, presented at the American Society of Clinical Oncology's annual meeting, have been hailed as "thrilling" and "unprecedented."